Learn more

SHANGHAI INST OF ENDOCRINE AND METABOLIC DISEASES

Overview
  • Total Patents
    38
  • GoodIP Patent Rank
    46,399
  • Filing trend
    ⇩ 44.0%
About

SHANGHAI INST OF ENDOCRINE AND METABOLIC DISEASES has a total of 38 patent applications. It decreased the IP activity by 44.0%. Its first patent ever was published in 2013. It filed its patents most often in China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HOSPITAL CLINIC BARCELONA, ANIMAL HEALTH TRUST and QINGDAO YANGSHEN BIOLOGICAL MEDICINE CO LTD.

Patent filings in countries

World map showing SHANGHAI INST OF ENDOCRINE AND METABOLIC DISEASESs patent filings in countries

Patent filings per year

Chart showing SHANGHAI INST OF ENDOCRINE AND METABOLIC DISEASESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ning Guang 33
#2 Wang Weiqing 17
#3 Hong Jie 7
#4 Liu Ruixin 6
#5 Gu Yanyun 6
#6 Zhang Zhiguo 6
#7 Zhang Yifei 5
#8 Zhao Hongyan 5
#9 Wang Jiqiu 5
#10 Sun Lihao 4

Latest patents

Publication Filing date Title
CN111202752A Ackermanella compositions
CN112075936A Health management all-in-one
CN110220987A Bile acid combines marker in preparation for predicting or diagnosing the detection reagent of diabetes or the purposes of detectable substance
CN109754854A A kind of diagnosis coding and the matched method and system of diagnosis name
CN109709228A Lipid combines marker in the detection reagent of preparation diagnosis diabetes or the purposes of detectable substance
CN108771682A Betulinic acid promotes the application of fatty acid oxidation
CN108478582A Application of the betulinic acid as aliphatic acid synthase inhibitor
CN108324927A Osteocalcin prepares the purposes for the treatment of Parkinsonian drugs
CN108897985A A kind of method and its application of Glycohemoglobin HbA1c genetic locus scoring
CN107854497A A kind of mouse model construction method of primary hyperparathyroidism state
CN107625775A A kind of antidiabetic drug is improving the application of people's intestines symbiosis Ruminococcus torques and UDCA abundance
CN107510697A A kind of antidiabetic drug is blocking the application of commensal gut bacterium secondary bile acid generation
CN107693525A Acarbose is delaying the application of tumor in digestive tract
CN107375262A Prebiotics containing OPC and its purposes in fat and metabolic syndrome medicine
CN107468679A Melbine is preparing the application in treating chromaffin cell tumor medicine
CN107684622A Purposes of the mTORC1 in regulation and control islet beta cell function and conversion medicine
CN107545144A pheochromocytoma branch prediction system based on molecular marker
CN107561283A Applications of the bone information mark CTX in abnormal carbohydrate metabolism Occurrence forecast system
CN106443024A LGR4 gene/protein for screening medicine for treating hypercholesteremia
CN105950771A ARMC5 gene detection kit and mutation site